
Colorectal cancer (CRC), a cancer of the large intestine and rectum, has one of the highest incidence and mortality rates, with incidences expected to nearly double in the next 25 years. The development of CRC may be caused by a collection of mutations via the chromosomal instability pathway, which results in approximately 70% of sporadic CRC cases, or the microsatellite instability pathway. At the same time, there are various modifiable and non-modifiable risk factors that increase one's chances of developing a CRC causing mutation via these pathways. There are three widely used treatments for CRC: surgical resection, chemotherapy, and immunotherapy. Surgical resection remains the standard for CRC that has not metastasized with various options available such as open surgery, laparoscopy, and robotic surgery. In recent years, there has also been a plethora of new research into chemotherapies and immunotherapies as important treatments for metastatic or complicated CRC cases. In this review, we highlight the pathogenesis, risk factors, and treatments for CRC, while also providing a short summary of the diagnosis. Such a study will be helpful for clinicians to better manage patients with CRC.
Citation: Derek A. Corica, Dylan M. Schaap, Trenton G. Mayberry, Braydon C. Cowan, Mark R. Wakefield, Yujiang Fang. New depths: exploring the current landscape of colorectal cancer[J]. AIMS Medical Science, 2025, 12(1): 105-123. doi: 10.3934/medsci.2025008
[1] | Cruz Vargas-De-León . Global analysis of a delayed vector-bias model for malaria transmission with incubation period in mosquitoes. Mathematical Biosciences and Engineering, 2012, 9(1): 165-174. doi: 10.3934/mbe.2012.9.165 |
[2] | Liqiong Pu, Zhigui Lin . A diffusive SIS epidemic model in a heterogeneous and periodically evolvingenvironment. Mathematical Biosciences and Engineering, 2019, 16(4): 3094-3110. doi: 10.3934/mbe.2019153 |
[3] | Chayu Yang, Jin Wang . Computation of the basic reproduction numbers for reaction-diffusion epidemic models. Mathematical Biosciences and Engineering, 2023, 20(8): 15201-15218. doi: 10.3934/mbe.2023680 |
[4] | Lin Zhao, Zhi-Cheng Wang, Liang Zhang . Threshold dynamics of a time periodic and two–group epidemic model with distributed delay. Mathematical Biosciences and Engineering, 2017, 14(5&6): 1535-1563. doi: 10.3934/mbe.2017080 |
[5] | Ling Xue, Caterina Scoglio . Network-level reproduction number and extinction threshold for vector-borne diseases. Mathematical Biosciences and Engineering, 2015, 12(3): 565-584. doi: 10.3934/mbe.2015.12.565 |
[6] | Pride Duve, Samuel Charles, Justin Munyakazi, Renke Lühken, Peter Witbooi . A mathematical model for malaria disease dynamics with vaccination and infected immigrants. Mathematical Biosciences and Engineering, 2024, 21(1): 1082-1109. doi: 10.3934/mbe.2024045 |
[7] | Azmy S. Ackleh, Keng Deng, Yixiang Wu . Competitive exclusion and coexistence in a two-strain pathogen model with diffusion. Mathematical Biosciences and Engineering, 2016, 13(1): 1-18. doi: 10.3934/mbe.2016.13.1 |
[8] | Rundong Zhao, Qiming Liu, Huazong Zhang . Dynamical behaviors of a vector-borne diseases model with two time delays on bipartite networks. Mathematical Biosciences and Engineering, 2021, 18(4): 3073-3091. doi: 10.3934/mbe.2021154 |
[9] | Yilong Li, Shigui Ruan, Dongmei Xiao . The Within-Host dynamics of malaria infection with immune response. Mathematical Biosciences and Engineering, 2011, 8(4): 999-1018. doi: 10.3934/mbe.2011.8.999 |
[10] | Wenzhang Huang, Maoan Han, Kaiyu Liu . Dynamics of an SIS reaction-diffusion epidemic model for disease transmission. Mathematical Biosciences and Engineering, 2010, 7(1): 51-66. doi: 10.3934/mbe.2010.7.51 |
Colorectal cancer (CRC), a cancer of the large intestine and rectum, has one of the highest incidence and mortality rates, with incidences expected to nearly double in the next 25 years. The development of CRC may be caused by a collection of mutations via the chromosomal instability pathway, which results in approximately 70% of sporadic CRC cases, or the microsatellite instability pathway. At the same time, there are various modifiable and non-modifiable risk factors that increase one's chances of developing a CRC causing mutation via these pathways. There are three widely used treatments for CRC: surgical resection, chemotherapy, and immunotherapy. Surgical resection remains the standard for CRC that has not metastasized with various options available such as open surgery, laparoscopy, and robotic surgery. In recent years, there has also been a plethora of new research into chemotherapies and immunotherapies as important treatments for metastatic or complicated CRC cases. In this review, we highlight the pathogenesis, risk factors, and treatments for CRC, while also providing a short summary of the diagnosis. Such a study will be helpful for clinicians to better manage patients with CRC.
Colorectal cancer;
Chromosomal instability pathway;
Microsatellite instability pathway;
Laparoscopic-assisted surgery;
Robot assisted surgery;
Immunotherapy;
Immune-related adverse events
Malaria is a lethal infectious disease caused by Plasmodium parasites, which infects humans through the bite of infected female geneus Anopheles mosquitoes. It is endemic in about 100 countries and an estimated 3.3 billion people are at risk of being infected in the word [1]. Therefore, it is necessary to study the spread of malaria in the population. The pioneering work was given by Ross [2] which showed that malaria is transmitted by mosquitoes and proposed the first mathematical model of this disease. Subsequently, Macdonald promoted this [3], which plays a particularly important role in understanding the disease. However, the Ross-Macdonald model is extremely simplified, ignoring many critical factors of real-world ecology and epidemiology [4]. One omission is spatial heterogeneity, for example, the distribution of urban and rural areas and the spatial movement of mosquitoes and people, which increases the spatial transmission of malaria. Hence, in the malaria epidemiological model, spatial heterogeneity must be considered [5,6,7]. In 1951, Skellam specially examined the reaction-diffusion model of species population density in a bounded habitat [8]. One advantage of reaction-diffusion models is that they can easily incorporate simple rules about edge effects. Use these features of reaction-diffusion model to study how environmental heterogeneity affects malaria [9,10,11]. However, in these studies, it seems that the following important biological aspects are rarely paid, simultaneously.
First, "vector-bias" is a typical feature of malaria transmission, which describes the different probabilities of a mosquito bitting humans. Lacroix et al. [12] proved that mosquitoes are generally more inclined to bite infected individuals. To describe this preference, Chamchod and Britton incorporated the vector-bias effect into malaria model [13]. Subsequently, a wealth of papers take into account the effect of vector-bias when studying malaria transmission [14,15,16]. Due to the different densities of mosquitoes in various regions, the infectivity of malaria is also different. The analysis of vector-bias effects is of great significance for understanding the dynamics of malaria transmission.
Secondly, in recent years, climate has become more fluctuating [17], and the rise in temperature is related to global warming. Climate warming is directly connected with the number of Anopheles, the main vector of malaria. Because temperature affects the immature development rate, immature stage survival rate, adult size, adult lifespan, blood feeding, and reproduction ability of mosquitoes [18]. It is widely accepted that both the life cycle of mosquitoes and the development of parasites are extremely sensitive to temperature. Empirical evidence indicates that the life cycle of mosquitoes experiences four different stages: eggs, larvae, pupae and adults. The first three stages are also called aquatic or immature stages [19]. In addition, a very important process in the development of parasites is the extrinsic incubation period (EIP), i.e., mosquitoes may not be able to transmit the disease to humans for a period of time after taking infected blood meal. The lifespan of female adult mosquitoes is generally 3 to 100 days, and EIP can reach 30 days [20]. These infected mosquitoes that live pass EIP will keep infectious until they die. There is considerable evidence that temperature rise will shorten the length of each immature stage [21] and EIP is extremely sensitive to seasonal changes in temperature [22,23]. In view of climate change, exploring the effect of temperature in the spread of malaria is particularly essential. Therefore, these seasonal forced EIP and mosquito life cycles need to be considered in the malaria model.
Note that mathematical models of malaria transmission rarely consider key features such as vector-bias, climate/seasonality, temperature-dependent mosquito life cycle and EIP in a spatially heterogeneous environment, simultaneously. A reaction-diffusion model with periodic delays is proposed to study the influence of the above factors on the transmission of malaria. This work is inspired by the following biological questions: (I) What is the impact of vector-bias on malaria transmission? (II) What effect does the maturity and incubation period of seasonal temperature changes have on the spread of malaria? (III) Does the movement of mosquitoes and humans have different effects for the transmission of malaria in different areas? These issues that are closely related to the spread and control of malaria need to be explored in more depth. How to add the temperature-dependent maturity period to the model is the first issue we consider, and the detailed model derivation is also the difficulty of this paper. The existence of temperature-dependent periodic delays makes it difficult to understand the asymptotic behavior of the model. We consider the stage structure, because the mosquitoes in the aquatic stage cannot fly, which makes it impossible for us to directly use the theoretical results in references [22,24]. Our theoretical results indicate the model has a threshold parameter, the basic reproduction number R0, which determines wether the malaria can persist or become extinct in susceptible populations.
The structure of the rest of this paper is shown below. Section 2 establishes human and mosquito populations models and malaria transmission model. This section also gives the biological significance of these parameters in models. Section 3 is devoted to well-posedness and some properties of the model. In Section 4, we first define the basic reproduction number R0, and then analyze the threshold dynamics of models in terms of R0. Section 5 gives the basic framework of the system threshold dynamics through numerical simulation, and discusses the influence of parameters on basic reproduction number, mosquitoes and humans in the process of malaria transmission. A brief discussion section concludes the paper.
Motivated by models in references [19,25,26], we introduce a seasonal stage-structured model of malaria to explain the cross-infection between mosquitoes and individuals. In this subsection, we first consider the mosquito population. According to the biological cycle, mosquitoes can go through several stages and have different habits at various stages. We divide them into immature aquatic stage M(t,x) and mature stage V(t,x) at time t≥0 and location x in a spatial bounded domain Ω∈Rn with smooth boundary ∂Ω. Let η(t,a,x) denote the density of the mosquito population at time t, chronological age a≥0, and location x. Metz and Diekmann [27] gave
{(∂∂t+∂∂a)η(t,a,x)=D(a)Δη(t,a,x)−d(t,a,x)η(t,a,x),η(0,a,x)=ˆϕ(a,x),a≥0,x∈ˉΩ,η(t,0,x)=Λv(t,x),t≥0,x∈ˉΩ, | (2.1) |
through the standard argument for structured populations and spatial diffusion. Here, Δ denotes the usual Laplacian operator. ˆϕ(⋅,x) represents the non-negative initial age and location distribution of mosquitoes, the term Λv(t,x) is the recruitment rate of the immature stage, which is Hölder continuous and nonnegative function on R×ˉΩ, D(a) is the age-related diffusion coefficient, and d(t,a,x) indicates the death rate of mosquitoes with time t, age a and location x, which is Hölder continuous and positive on R×ˉΩ. Λv(t,⋅) and d(t,⋅,⋅) are periodic in t and have the same period ω.
Let us first assume some age thresholds so that the growth of mosquitoes can be divided into discrete age stages. When modeling species dynamics with a stage structure, we divide mosquitoes into immature stage (also known as aquatic stage) and mature stage, the time delay is the mature period. The temperature T(t) is an ω-periodic function of time t. Generally speaking, the maturity age is determined by seasonal changes in temperature. We will use a time-dependent positive function τ1(t) to describe the duration from newborn to adult. That is, an individual at time t becomes mature only if its age exceeds τ1(t), in other words, the adult mosquitoes that develop at time t enter the aquatic stage at t−τ1(t). We assume that the maximum chronological age of aquatic mosquitoes at time t is A(t). Here and in the following, τ1(t) and A(t) are C1 (a section of continuous differentiable functions) periodic functions of time t with the same periodic ω. The relationship between time-dependent threshold age and time-dependent delay can be indicated as follows:
A(t)=τ1(t). |
Here we introduce another quantity f to describe the maturity level of mosquitoes. Let f=fM=0, that is, the maturity level of mosquitoes that have just entered the aquatic stage is 0. At time t, the mosquitoes reach the maximum chronological age A(t) of the aquatic stage. At this time, the maturity level is also the maximum, fV. Then one has
fV−fM=∫tt−τ1(t)ˆρ(r1)dr1 |
where ˆρ(r1) is the proportion of maturity at time r1. Taking the derivative of the above formula with respect to t, we can get
1−τ′1(t)=ˆρ(t)ˆρ(t−τ1(t)), |
and hence 1−τ′1(t)>0. Recall that τ1(t) represents the time it takes for a mosquito to go from the aquatic stage to the adult stage at time t. For the case where δ>0 is small enough, if the mosquito is an adult mosquito at time t, then it is still an adult mosquito at time t+δ. Thus τ1(t+δ)<τ1(t)+δ, and hence, τ′1(t)=limδ→0τ1(t+δ)−τ1(t)δ≤1. This condition also makes sense biologically. 1−τ′1(t)>0, is called maturation rate [26], which excludes the possibility of mosquitoes returning from the mature stage to the immature stage unless they are born. Mathematically speaking, t−τ1(t) is strictly increased with respect to t, that is, since the developmental rate depends only on time, it is impossible for juveniles to reach maturity before they are born.
M(t,x) and V(t,x) denote the density of mosquitoes in the aquatic and mature stages at time t and location x, respectively. The accumulative density between the two age thresholds can be recorded as the population size at each stage. In particular, for the aquatic stage M and the mature stage V (for the sake of simplicity, we use M and V instead of M(t,x) and V(t,x), respectively), we have the following mathematical expressions:
M=∫A(t)0η(t,a,x)da,V=∫∞A(t)η(t,a,x)da. | (2.2) |
Next, we put forward natural biological assumptions about birth rate, death rate and diffusion coefficient in Eq (2.1). Since immature mosquitoes cannot fly, we assume that the diffusion coefficient satisfies
D(a)={0,0≤a<A(t),Dv,a≥A(t). |
At each age stage, all mosquitoes undergo the same birth rate and death rate which are age-independent, then the natural death rates in the aquatic and mature stages are μm(t,x) and μv(t,x), respectively, i.e.,
d(t,a,x)={μm(t,x),0≤a<A(t),μv(t,x),a≥A(t), |
where μm(t,x) and μv(t,x) are non-negative non-trivial and Hölder continuous on R×ˉΩ and ω-periodic in t. Differentiating the equations in system (2.2) with respect to time t on both sides yields
∂M∂t=∫A(t)0∂η(t,a,x)∂tda+η(t,A(t),x)A′(t)=−μm(t,x)M−η(t,A(t),x)+η(t,0,x)+η(t,A(t),x)A′(t), |
and
∂V∂t=∫∞A(t)∂η(t,a,x)∂tda−η(t,A(t),x)A′(t)=DvΔV−μv(t,x)V−η(t,∞,x)+(1−A′(t))η(t,A(t),x). |
In a biological sense, because no mosquito can live forever, η(t,∞,x)=0. η(t,0,x) represents the inflow rate of mosquitoes in the aquatic stage at time t, then η(t,0,x)=Λv(t,x) is a function of t.
{∂M∂t=Λv(t,x)−μm(t,x)M−(1−A′(t))η(t,A(t),x),∂V∂t=DvΔV−μv(t,x)V+(1−A′(t))η(t,A(t),x). |
Mathematically, assume that the delay τ1(t) is continuously differentiable in [0,∞), bounded and far away from zero and infinity. The expression of η(t,A(t),x) in the above system will be obtained by integrating along characteristics. For t≥A(t) and t<A(t), η(t,A(t),x) has different expressions. Without loss of generality, we study t≥A(t) (see, [28]), which is practicable due to the boundedness of A(t), because we are concerned with long-term behavior of population dynamics. Here, η(t−τ1(t),0,⋅)=Λv(t−τ1(t),⋅). Let t=t0+h, a=a0+h, P(h,x)=η(t0+h,a0+h,x) and ˆd(h,x)=d(t0+h,a0+h,x), then
∂P(h,x)∂h=∂η(t0+h,a0+h,x)∂h⋅dhdt+∂η(t0+h,a0+h,x)∂h⋅dhda=(∂∂t+∂∂a)η(t,a,x)=DvΔP(h,x)−ˆd(h,x)P(h,x). | (2.3) |
Integrating Eq (2.3) from h1 to h2 yields
P(h2,x)=P(h1,x)e−∫h2h1ˆd(r2,⋅)dr2. |
For t≥A(t), setting t0=t−A(t), h=A(t) and a0=0, we have
η(t,A(t),x)=η(t−A(t),0,x)e−∫tt−A(t)μm(r2,x)dr2=Λv(t−τ1(t),x)e−∫tt−τ1(t)μm(r2,x)dr2. |
Since we are concerned about the long-term behavior of population dynamics, the model for t≥A(t) is as follows
{∂M∂t=Λv(t,x)−μm(t,x)M−(1−τ′1(t))Λv(t−τ1(t),x)e−∫tt−τ1(t)μm(r2,x)dr2,x∈Ω,∂V∂t=DvΔV−μv(t,x)V+(1−τ′1(t))Λv(t−τ1(t),x)e−∫tt−τ1(t)μm(r2,x)dr2,x∈Ω,∂V∂ν=0,x∈∂Ω, | (2.4) |
where ν is the outward unit normal vector on ∂Ω and ∂∂ν indicates the normal derivative along ν on ∂Ω, e−∫tt−τ1(t)μm(r2,x)dr2 represents probability surviving through natural death during aquatic stage. It is easy to see that the equation V(t,x) is decoupled, so we can get the following system
{∂V∂t=DvΔV−μv(t,x)V+(1−τ′1(t))Λv(t−τ1(t),x)e−∫tt−τ1(t)μm(r2,x)dr2,x∈Ω,∂V∂ν=0,x∈∂Ω. | (2.5) |
for any t≥A(t). Alternatively, according to biological significance, M and V can be written as integral form. Note that τ1(t) is the maturation time of aquatic mosquitoes at time t. Thence, aquatic mosquitoes at time t contain all newly born mosquitoes at a previous time ξ1 with ξ1∈(t−τ1(t),t) and survive to time t. Hence, one has
M=∫tt−τ1(t)Λv(ξ1,x)e−∫tξ1μm(r2,x)dr2dξ1,∀x∈ˉΩ. | (2.6) |
Similarly, for any x∈ˉΩ,
V=∫ΩΓ(t,0,x,y)V(0,y)dy+∫t0∫ΩΓ(t,ξ1,x,y)Λv(ξ1−τ1(ξ1),y)(1−τ′1(ξ1))e−∫ξ1ξ1−τ1(ξ1)μm(r2,⋅)dr2dydξ1, | (2.7) |
where V(0,⋅) is the initial data of V(t,⋅).
The first term in Eq (2.7) represents those mosquitoes that were adults at time 0 at position y and are still in V class at time t at position x by diffusion. The second term in Eq (2.7) denotes the total density of mosquitoes at time t. These mosquitoes were newly developed adults at time ξ1 and survived until time t. These new adults developed from the aquatic stage at previous time ξ1−τ1(ξ1), which grown through τ1(ξ1) periodic of time and developed into adult stage at time ξ1 with "maturation rate" 1−τ′1(ξ1). Γ(t,t0,x,y) with t≥t0≥0 is the Green function related to ∂V∂t=DvΔV−μv(t,x)V that meets the Neumann boundary condition.
Since the incubation period of the pathogen in the human is 1–12 days, which is short compared with the human life span, we do not consider the incubation period of the pathogen in the human body. In this subsection, inspired by [13,19,20,24,29], we give a model of malaria transmission, including the mobility of mosquitoes and individuals, vector-bias, temperature-dependent maturation delay and EIP. Because mosquitoes are the vectors of malaria transmission from person to person, the modeling takes into account the dynamics of human and mosquito populations. One supposes that individuals will become susceptible again after recovery. Thus, humans include two epidemiological types: susceptible (Sh) and infected (Ih) compartments. Assume that all populations walk unbiased and random. Since climate change has almost no impact on human birth and death, according to [29], the following reaction-diffusion equation is suitable:
∂Nh(t,x)∂t=DhΔNh(t,x)+Λh(x)−μh(x)Nh(t,x),t>0,x∈ˉΩ. | (2.8) |
Dh>0 is the human diffusion coefficient. Suppose the dispersal pattern is random diffusion, that is, individual walkers use a fixed step to walk randomly on the solid line [30,31]. Λh(x) and μh(x) are the recruitment rate and natural death rate of human at location x, respectively. In particular, we should note that the disease dose not have a significant impact on the mobility of individuals and mosquitoes. It is mathematically assumed that the diffusion coefficient Dh>0 of all individuals is the same, and the diffusion coefficient Dv>0 of all mosquitoes is recognized as the same. Assuming that no population flow crosses the boundary ∂Ω, therefore, the Neumann boundary condition is imposed:
∂Nh(t,x)∂ν=0,t>0,x∈∂Ω, | (2.9) |
here, the definition of ν is same as Section 2.1. Following Theorems 3.1.5 and 3.1.6 in reference [32] and Section 2 in reference [29], we realize that the positive steady state N(x)∈C(ˉΩ,R+)∖{0} of systems (2.8) and (2.9) is globally attractive, where C(ˉΩ,R+) is Banach space of continuous functions from ˉΩ to R+. According to Appendix 8.1 in reference [33], it is assumed that the total human density of at time t and location x is stable at N(x), i.e., Nh(t,x)≡N(x), for ∀t≥0 and x∈Ω. Then we know that Sh=N(x)−Ih. Here and later, for the sake of simplicity, we use Sh and Ih instead of Sh(t,x) and Ih(t,x), respectively.
From a biological and epidemiological point of view, immature mosquitoes do not take part in infection, and are primarily in a waiting period, because they cannot fly and bite humans. Since adult male mosquitoes do not eat blood meal, they cannot transmit and acquire the virus, so only adult female mosquitoes are modeled. Mature female mosquitoes are divided into susceptible (Sv(t,x)), exposed (Ev(t,x)) and infectious (Ev(t,x)), t is time and x denotes location. The exposed mosquitoes are already infected, but not infectious. From Section 2.1, we know that V=Sv+Ev+Iv is the total density of female adult mosquitoes and satisfies reaction-diffusion system (2.5). Here and later, for the sake of simplicity, we use V, Sv, Ev and Iv instead of V(t,x), Sv(t,x), Ev(t,x) and Iv(t,x), respectively.
Vector-bias effect is a situation in which mosquitoes display the weight of preference when choosing a host. In order to add a vector-bias term to the model, parameters p and l are introduced, which are the probability of mosquitoes arriving at humans randomly, and select infectious and susceptible humans, respectively [13]. Since mosquitoes are more attracted to infected humans, we assume that the vector-bias parameter χ=pl≥1. To comprehend the influences of spatial structure and climate change, we allow a space-dependent bite rate β(t,x) of female mosquitoes to be Hölder continuous non-negative non-trivial on R×ˉΩ with β(t,x)≢0, representing the number of mosquitoes biting per unit time at location x, and β(t,⋅) is a ω-period function of time t. Let B represent the mosquitoes bite incident, and A be the event of mosquitoes reaching humans infected with malaria. Then P(A)=IhN(x), P(Ac)=1−IhN(x), P(B|A)=p and P(B|Ac)=l. So the probability that an infectious human is chosen as P(A|B),
then one has
P(Ac|B)=l[N(x)−Ih]pIh+l[N(x)−Ih]andP(A|B)=pIhpIh+l[N(x)−Ih], |
which are the probability of infected individuals and susceptible individuals are bitten. Then at time t and location x, the numbers of newly infected individuals and mosquitoes per unit time are
cβ(t,x)l[N(x)−Ih]IvpIh+l[N(x)−Ih]andαβ(t,x)pIhSvpIh+l[N(x)−Ih], |
respectively, where c is the probability that an infected mosquito will spread to susceptible individuals per bite, and α is probability that an infected individual will transmission to susceptible mosquitoes per bite.
During the malaria transmission cycle, the EIP of parasite in mosquitoes is one of the most pivotal parameters. Mosquitoes can fly around during EIP. The malaria parasites undergo different growth stages before migrating to the salivary glands where can spread to humans. The degree of this development is related to environmental factors, such as temperature. EIP is exceedingly sensitive to temperature. Therefore, it is necessary to incorporate this seasonal forced incubation period when describing malaria transmission. We will use a time-dependent positive function τ2(t) to describe the duration from new infection to infectiousness. That is, a mosquito is infectious at time t only if its age of infection exceeds τ2(t), where τ2(t) is a C1 periodic function in [0,∞) with the periodic ω, and t−τ2(t) is strictly increasing in t.
Based on the above discussions, we will pay attention to the dynamics of the following malaria transmission reaction-diffusion model
{∂M∂t=Λv(t,x)−(1−τ′1(t))Λv(t−τ1(t),x)e−∫tt−τ1(t)μm(r2,x)dr2−μm(t,x)M,x∈Ω,∂Sv∂t=DvΔSv+(1−τ′1(t))Λv(t−τ1(t),x)e−∫tt−τ1(t)μm(r2,x)dr2−αβ(t,x)pIhSvpIh+l[N(x)−Ih]−μv(t,x)Sv,x∈Ω,∂Ev∂t=DvΔEv−Em(t,x)−μv(t,x)Ev+αβ(t,x)pIhSvpIh+l[N(x)−Ih],x∈Ω,∂Iv∂t=DvΔIv+Em(t,x)−μv(t,x)Iv,x∈Ω,∂Ih∂t=DhΔIh−(μh(x)+ϱ(x))Ih+cβ(t,x)l[N(x)−Ih]IvpIh+l[N(x)−Ih],x∈Ω,∂Sv∂ν=∂Ev∂ν=∂Iv∂ν=∂Ih∂ν=0,x∈∂Ω, | (2.10) |
for t>0. Similar to the derivation in Section 2.1, we get
Em(t,x)=(1−τ′2(t))∫ΩΓ(t,t−τ2(t),x,y)αβ(t−τ2(t),y)pIh(t−τ2(t),y)Sv(t−τ2(t),y)pIh(t−τ2(t),y)+l[N(y)−Ih(t−τ2(t),y)]dy. |
Substituting Em(t,x) into system (2.10), one has
{∂M∂t=Λv(t,x)−(1−τ′1(t))Λv(t−τ1(t),x)e−∫tt−τ1(t)μm(r,x)dr−μm(t,x)M,x∈Ω,∂Sv∂t=DvΔSv+(1−τ′1(t))Λv(t−τ1(t),x)e−∫tt−τ1(t)μm(r,x)dr−αβ(t,x)pIhSvpIh+l[N(x)−Ih]−μv(t,x)Sv,x∈Ω,∂Ev∂t=DvΔEv+αβ(t,x)pIhSvpIh+l[N(x)−Ih]−μv(t,x)Ev−(1−τ′2(t))⋅∫ΩΓ(t,t−τ2(t),x,y)αβ(t−τ2(t),y)pIh(t−τ2(t),y)Sv(t−τ2(t),y)pIh(t−τ2(t),y)+l[N(y)−Ih(t−τ2(t),y)]dy,x∈Ω,∂Iv∂t=DvΔIv−μv(t,x)Iv+(1−τ′2(t))∫ΩΓ(t,t−τ2(t),x,y)⋅αβ(t−τ2(t),y)pIh(t−τ2(t),y)Sv(t−τ2(t),y)pIh(t−τ2(t),y)+l[N(y)−Ih(t−τ2(t),y)]dy,x∈Ω,∂Ih∂t=DhΔIh−(μh(x)+ϱ(x))Ih+cβ(t,x)l[N(x)−Ih]IvpIh+l[N(x)−Ih],x∈Ω,∂Sv∂ν=∂Ev∂ν=∂Iv∂ν=∂Ih∂ν=0,x∈∂Ω, | (2.11) |
for t>0, where α, p, l and c are positive constants, and ϱ(x) denotes the recovery rate of humans in position x, which is Hölder continuous and positive on Ω. Neumann boundary condition indicates that all individuals and mosquitoes still remain in this domain Ω.
Since M(t,x) and Ev(t,x) of the system (2.11) are decoupled from the other equations, it is sufficient to explore the system
{∂u1∂t=DvΔu1−μv(t,x)u1+(1−τ′1(t))Λv(t−τ1(t),x)e−∫tt−τ1(t)μm(r,x)dr−αβ(t,x)pu3u1pu3+l[N(x)−u3],x∈Ω,∂u2∂t=DvΔu2−μv(t,x)u2+(1−τ′2(t))∫ΩΓ(t,t−τ2(t),x,y)⋅αβ(t−τ2(t),y)pu3(t−τ2(t),y)u1(t−τ2(t),y)pu3(t−τ2(t),y)+l[N(y)−u3(t−τ2(t),y)]dy,x∈Ω,∂u3∂t=DhΔu3+cβ(t,x)l[N(x)−u3]u2pu3+l[N(x)−u3]−(μh(x)+ϱ(x))u3,x∈Ω,∂u1∂t=∂u2∂t=∂u3∂t=0,x∈∂Ω, | (2.12) |
for t>0, where (u1,u2,u3)=(Sv,Iv,Ih).
In this section, the well-posedness of the model is proved. Let X1:=C(ˉΩ,R3) be the Banach space of continuous functions from ˉΩ to R3 the supremum norm be ‖⋅‖X, and X+1:=C(ˉΩ,R3+). Let ˆτ1:=maxt∈[0,ω]τ1(t), ˆτ2:=maxt∈[0,ω]τ2(t), and ˆτ:=max{ˆτ1,ˆτ2}. Define X1:=C([−ˆτ,0],X1) to be a Banach space, with the norm ‖ϕ‖=maxθ∈[−ˆτ,0]‖ϕ(θ)‖X1, ∀ϕ∈X1, and X+1:=C([−ˆτ,0],X+1). Then (X1,X+1) and (X1,X+1) are order Banach spaces. A function z:[−ˆτ,σ)→X1 for σ>0 is given and zt∈X1 is defined by
zt(θ)=(z1(t+θ),z2(t+θ),z3(t+θ)),∀θ∈[−ˆτ,0], |
for any t∈[0,σ).
Denote Y:=C(ˉΩ,R), Y+:=C(ˉΩ,R+), Yh:={φ∈Y+:0≤φ(x)≤N(x),∀x∈ˉΩ}. Suppose that T1(t,s),T2(t,s):Y→Y, are the evolution operators associated
∂u1∂t=DvΔu1−μv(t,x)u1(t,x):=A1(t)u1, |
and
∂u3∂t=DhΔu3−(μh(x)+ϱ(x))u3:=A2u3, |
obey the Neumann boundary condition, respectively. Since Ti(t,s)=Ti(t−s) (i=1,2) and μv(t,⋅) is ω-periodic in t, = [34,Lemma 6.1] indicates that Ti(t+ω,s+ω)=Ti(t,s) for (t,s)∈R2 with t≥s. Furthermore, Ti(t,s) is compact and strongly positive [35,Section 7.1 and Corollary 7.2.3] for (t,s)∈R2 with t>s (i=1,2). Let T(t,s)=diag{T1(t,s),T1(t,s),T2(t,s)}:X1→X1, t≥s, is a strongly continuous semigroup and A(t)=diag{A1(t),A1(t),A2}, defined on D(A(t))=D(A1(t))×D(A1(t))×D(A2). A1(t) is defined by
D(A1(t)):={φ∈C2(ˉΩ):∂φ∂ν=0on∂Ω},A1(t)φ=DvΔφ−μv(t,x)φ,∀φ∈D(A1(t)), |
and A2 is defined by
D(A2):={φ∈C2(ˉΩ):∂φ∂ν=0on∂Ω},A2φ=DhΔφ−(μh(x)+ϱ(x))φ,∀φ∈D(A2). |
Set
Wh=C([−ˆτ,0],Y+×Y+×Yh). |
Write F=(F1,F2,F3):[0,∞)×Wh→X1 as
{F1(t,ϕ)=(1−τ′1(t))Λv(t−τ1(t),⋅)e−∫tt−τ1(t)μm(r2,⋅)dr2−αβ(t,⋅)pϕ3(0,⋅)ϕ1(0,⋅)pϕ3(0,⋅)+l[N(⋅)−ϕ3(0,⋅)],F2(t,ϕ)=(1−τ′2(t))∫ΩΓ(t,t−τ2(t),⋅,y)αβ(t−τ2(t),y)pϕ3(−τ2(t),y)ϕ1(−τ2(t),y)pϕ3(−τ2(t),y)+l[N(y)−ϕ3(−τ2(t),y)]dy,F3(t,ϕ)=cβ(t,⋅)l[N(⋅)−ϕ3(0,⋅)]ϕ2(0,⋅)pϕ3(0,⋅)+l[N(⋅)−ϕ3(0,⋅)], | (3.1) |
for t≥0, x∈ˉΩ and ϕ=(ϕ1,ϕ2,ϕ3)∈Wh. Rewrite system (2.12) as
{du∂t=A(t)u+F(t,ut),t>0,u0=ϕ, | (3.2) |
it then follows from references [36,Corollary 4 and Theorem 1] and [37,Corollary 8.1.3] that for any ϕ∈Wh, a mild solution can be get as a continuous solution of the integral equation:
{u(t,ϕ)=T(t,0)ϕ(0)+∫t0T(t,s)F(s,us)ds,∀t>0,u0=ϕ. | (3.3) |
Lemma 3.1. For any ϕ∈Wh, system (2.12) has the unique solution, denoted by z(t,⋅,ϕ) on its maximal existence interval [0,tϕ) with z0=ϕ, where tϕ≤∞.Moreover, z(t,⋅,ϕ)∈Y+×Y+×Yh for any t∈[0,tϕ), andthis solution is a classical solution of system (2.12) for all t>ˆτ.
Before studying the global existence, go back to system (2.11) to make more information. We impose the compatibility conditions based on the biological meaning of τ1(t) and τ2(t):
M(0,⋅)=∫0−τ1(0)Λv(ξ1,⋅)e−∫0ξ1μm(r2,⋅)dr2dξ1, | (3.4) |
and
Ev(0,⋅)=∫0−τ2(0)T1(0,ξ1)αβ(ξ1,⋅)pIh(ξ1,⋅)Sv(ξ1,⋅)pIh(ξ1,⋅)+l[N(⋅)−Ih(ξ1,⋅)]dξ1. | (3.5) |
Now we define
D:={ψ∈C([−ˆτ,0],C(ˉΩ,R5+)):ψ5(s,⋅)≤N(⋅),∀s∈[−ˆτ,0],ψ1(0,⋅)=∫0−τ1(0)Λv(ξ1,⋅)e−∫0ξ1μm(r2,⋅)dr2dξ1,ψ3(0,⋅)=∫0−τ2(0)T1(0,ξ1)αβ(ξ1,⋅)pIh(ξ1,⋅)Sv(ξ1,⋅)pIh(ξ1,⋅)+l[N(⋅)−Ih(ξ1,⋅)]dξ1}. |
Next, for any ψ∈D, system (2.11) has the unique solution U(t,⋅)=(M(t,⋅),Sv(t,⋅),Ev(t,⋅),Iv(t,⋅),Ih(t,⋅)) satisfying U0=ψ. Corollary 4 in reference [36] implies that Sv(t,x)≥0, Iv(t,x)≥0 and Ih(t,x)≥0 on maximal existence interval. According to the uniqueness of the solutions and the compatibility conditions (3.4) and (3.5), one has M(t,⋅) (see(2.6)) and
Ev(t,⋅)=∫tt−τ2(t)T1(t,ξ1)αβ(ξ1,⋅)pIh(ξ1,⋅)Sv(ξ1,⋅)pIh(ξ1,⋅)+l[N(⋅)−Ih(ξ1,⋅)]dξ1. | (3.6) |
Hence, M(t,x)≥0 and Ev(t,x)≥0 on the maximal interval of existence.
Lemma 3.2. For any ϕ∈Wh, system (2.12)has a unique solution u(t,⋅,ϕ) on [0,∞) with u0=ϕ.Moreover, system (2.12) generates an ω-periodic semiflowQt:Wh→Wh, defined by Qt:=ut(⋅), ∀t≥0, i.e., Qt(ϕ)(s,x)=u(t+s,x,ϕ), ∀ϕ∈Wh, t≥0, s∈[−ˆτ,0], x∈Ω, and Q:=Qω has a strong global attractor in Wh.
The proof of Lemma 3.2 is given in Appendix A.
Here, the basic reproduction number are introduced by the theory in reference [41], and then investigate the dynamics of system (2.12).
The current main work is to explore the extinction and persistence of malaria in a spatially heterogeneous environment. The basic reproduction number R0 is one of the most necessary concepts in epidemiology. It is usually defined as the mean number of secondary infections during the entire period when a typical infected person is introduced into a completely susceptible population. From a biological point of view, the basic reproduction number is a characteristic of the risk of infection. More meaningfully, it describes the threshold behavior of many infectious disease models.
Let u2=u3=0, we have the equation of mosquitoes compartment
∂u1∂t=DvΔu1+(1−τ′1(t))Λv(t−τ1(t),x)e−∫tt−τ1(t)μm(r2,x)dr2−μv(t,x)u1, | (4.1) |
obeys the Neumann boundary condition. Based on reference [38,Lemma 2.1], it is easy to know that system (4.1) has a unique globally attractive positive ω-periodic solution u∗1(t,⋅) in Y+∖{0}. Linearize system (2.12) at (u∗1(t,⋅),0,0) and consider the equations of infectious compartments,
{∂w1∂t=DvΔw1−μv(t,x)w1+(1−τ′2(t))∫ΩΓ(t,t−τ2(t),x,y)⋅αβ(t−τ2(t),y)pw2(t−τ2(t),y)u∗1(t−τ2(t),y)lN(y)dy,x∈Ω,∂w2∂t=DhΔw2+cβ(t,x)w1−(μh(x)+ϱ(x))w2,x∈Ω,∂w1∂ν=∂w2∂ν=0,x∈∂Ω, | (4.2) |
for t>0. Denote w:=(w1,w2)=(u2,u3).
Set X2:=C(ˉΩ,R2), X+2:=C(ˉΩ,R2+), and Cω(R,X2) to be the Banach space consisting of all ω-periodic and continuous functions from R to X2, where ‖ψ‖Cω(R,X2):=maxθ∈[0,ω]‖ψ(θ)‖X2 for any ψ∈Cω(R,X2). Let X2:=C([−ˆτ2,0],X2) and X+2:=C([−ˆτ2,0],X+2). Write F(t):X2→X2 as
F(t)(˜ψ1˜ψ2)=((1−τ′2(t))∫ΩΓ(t,t−τ2(t),⋅,y)αβ(t−τ2(t),y)p˜ψ2(−τ2(t),y)u∗1(t−τ2(t),y)lN(y)dycβ(t,⋅)˜ψ1(0,⋅)) |
for any t∈R, ˜ψ=(˜ψ1,˜ψ2)∈X2 and −V1(t)w=ˉDΔw−W(t)w, where ˉD=diag(Dv,Dh) and
−[W(t)](x)=(−μv(t,x)00−(μh(x)+ϱ(x))),x∈ˉΩ. |
Denote that Φ(t,s)=diag(T1(t,s),T2(t,s)) is an evolution operator related to the following system
dwdt=−V1(t)w, | (4.3) |
t≥s, with the Neumann boundary condition. Obviously, Φ(t,s) is a positive operator, that is, Φ(t,s)X+2⊆X+2 for all t≥s. Then −V1(t) is resolvent positive, based on reference [39,Theorem 3.12].
The exponential growth bound of Φ(t,s) can be written as
ˉω=inf{˜ω:∃L≥1suththat‖Φ(t+s,s)≤Le˜ωt‖,∀s∈R,t≥0}. |
By [39,Proposition A.2], one has
ˉω(Φ)=lnr(Φ(ω+ˉs,ˉs))ω,ˉs∈[0,ω]. |
According to Krein-Rutman theorem and [40,Lemma 14.2], one has
0<r(Φ(ω,0))=max{r(T1(ω,0)),r(T2(ω,0))}<1, |
here, r(Φ(ω,0)) denotes the spectral radius of Φ(ω,0). By [39,Proposition 5.6] with s=0, we obtain ˉω(Φ)<0. Obviously, F(t) and W(t) meet the assumptions: (1) F(t):X2→X2 is positive, i.e., F(t)X+2⊆X+2, for any t≥0. (2) −W(t) is cooperative, and ˉω(Φ)<0.
To introduce R0 of system (2.12) based on references [41] and [42], it is assumed that both human and mosquito populations are close to (u∗1(t,⋅),0,0). Suppose w∈Cω(R,X2), and w(t)=w(t) is the initial distribution of infected mosquitoes and humans at t∈R. For any fixed s≥0, the distribution of newly infected mosquitoes and individuals at time t−s (t≥s) is F(t−s)wt−s, which is engendered by the infectious mosquitoes and humans introduced in [t−s−ˆτ2,t−s]. Thus, the distribution of infectious who were newly infected at time t−s and keep survive at time t, is Φ(t,t−s)F(t−s)wt−s, t≥s. Then, at time t, the distribution of the accumulative infectious humans and mosquitoes produced by all people introduced to t at all previous times is
∫+∞0Φ(t,t−s)F(t−s)wt−sds=∫+∞0Φ(t,t−s)F(t−s)w(t−s+⋅)ds. |
Define the next generation operator L associated with system (2.12) as
[Lw](t):=∫+∞0Φ(t,t−s)F(t−s)w(t−s+⋅)ds,∀t∈R,w∈Cω(R,X2). |
Inspired by the definition of next generation operators in references [39,42], the basic reproduction number of system (2.12) is defined by the spectral radius L, i.e.,
R0:=r(L). | (4.4) |
For any ˜ψ∈X2, set ˉQt to be solution map of system (4.2) on X2, i.e., ˉQt(˜ψ)=wt(˜ψ), t≥0, where wt(˜ψ)(θ)(x)=w(t+θ,x,˜ψ)=(w1(t+θ,x,˜ψ),w2(t+θ,x,˜ψ)), and w(t,x,˜ψ) is the unique solution of system (4.2) with w(θ,x)=˜ψ(θ,x) for all θ∈[−ˆτ2,0], x∈ˉΩ. Thus ˉQ:=ˉQω is the Poincaré map related to system (4.2). r(ˉQ) represents the spectral radius of ˉQ. Based on reference [41,Theorem 3.7], the following result can be obtained.
Lemma 4.1. R0−1 has the same sign as r(ˉQ)−1.
To explore the global dynamic behaviors of system (2.12) according to R0, we demonstrate that system (4.2) engenders an eventually strong monotone periodic semiflow on the phase space:
E1:=Y×C([−τ2(0),0],Y),andE+1:=Y×C([−τ2(0),0],Y+). |
Thus (E1,E+1) is an ordered Banach space. For every ˆψ∈E+1, ˜w(t,x,ˆψ)=(˜w1(t,x,ˆψ),˜w2(t,x,ˆψ)) denotes the unique solution of (4.2) with ˜w0(ˆψ)(θ,x) for x∈ˉΩ, θ∈[−τ2(0),0], where
˜wt(ˆψ)(θ,x)=˜w(t+θ,x,ˆψ)=(˜w1(t,x),˜w2(t+θ2,x)),∀θ∈[−τ2(0),0],∀t≥0. |
Lemma 4.2. For any ˆψ∈E+1, system (4.2)has a unique nonnegative solution ˜w(t,⋅,ˆψ) on [0,∞)with ˜w0=ˆψ.
The proof of Lemma 4.2 is given in Appendix B.
Remark 1. Through the uniqueness of solutions in Lemmas 3.2 and 4.2, then for any ˜ψ∈X+2 and ˆψ∈E+1 with ˜ψ1(⋅)=ˆψ1(⋅) and ˜ψ2(θ,⋅)=ˆψ2(θ,⋅), ∀θ∈[−τ2(0),0], one has w(t,⋅,˜ψ)=˜w(t,⋅,ˆψ), t≥0, where w(t,⋅,˜ψ) and ˜w(t,⋅,ˆψ) are solutions of system (4.2) meeting w0=˜ψ and ˜w0=ˆψ, respectively.
For every fixed t≥0, let ˜Qt be the solution map of system (4.2) on the space E1, i.e., ˜Qt(ˆψ)=˜wt(ˆψ), for t≥0 and ∀ˆψ∈E1. Thus, ˜Q:=˜Qω is the Poincaré map related to system (4.2) and r(˜Q) is the spectral radius of ˜Q. The next lemma indicates that the periodic semiflow ˜Qt is eventually strongly positive.
Lemma 4.3. For each ξ in E+1, with ξ≢0, the solution ˜w(t,⋅,ξ) of (4.2) with ˜w0=ξ, meets ˜wi(t,⋅)>0 (i=1,2) for all t>2ˆτ, therefore, ˜Qtξ≫0 for every t>3ˆτ.
The proof of Lemma 4.3 is given in Appendix C.
Fix an integer n0 satisfying n0ω>3ˆτ. Obviously, ˜Qn0=˜Qn0ω is strongly monotone, according to proof of Lemma 4.3. In addition, through similar arguments in reference [43,Lemma 2.6], one can get that ˜Qn0 is compact. Apply the Krein-Rutman theorem to the linear operator ˜Qn0, and because r(˜Qn0)=(r(˜Q))n0, one has ˉλ=r(˜Q)>0, among them ˉλ is the simple eigenvalue of ˜Q and there is a eigenvector ϑ∈Int(E+1) that is strongly positive. Based on reference [22,Lemma 3.8], one has the following lemma.
Lemma 4.4. The spectral radii of the two Poincaré maps ˉQ:X2→X2and ˜Q:E1→E1 are the samei.e., r(ˉQ)=r(˜Q).Furthermore, R0−1 has the same sign as r(˜Q)−1.
The fact that system has a special solution is given by the following lemma, which can be used to study long-term dynamics. The following argument is inspired by references [29,Lemma 5] and [44,Proposition 1.1].
Lemma 4.5. There is a positive ω-periodic function w∗(t,x), such that e˜μtw∗(t,x) is a solution of (4.2), where ˜μ=lnr(˜Q)ω.
The proof of Lemma 4.5 is given in Appendix D.
Next, we use R0 to give the threshold results of the global dynamics of system (2.12).
Denote
E2:=C([−τ2(0),0],Y+)×Y+×C([−τ2(0),0],Yh). | (4.5) |
Through similar arguments in Lemma 4.2, it can be concluded that for any ϕ∈Wh and ˉφ∈E2 with ϕ1(θ,⋅)=ˉφ1(θ,⋅), ϕ2(0,⋅)=ˉφ2(⋅), and ϕ3(θ,⋅)=ˉφ3(θ,⋅), ∀θ∈[−τ2(0),0], z(t,⋅,ϕ)=ˉz(t,⋅,ˉφ) is established, t≥0, where z(t,⋅,ϕ) and ˉz(t,⋅,ˉφ) are solutions of system (2.12) meeting z0=ϕ and ˉz0=ˉφ, respectively. Then we get that solutions of system (2.12) on E2 exist globally on [0,+∞) and ultimately bounded. In addition, it is easy to get the next result based on the discussion on references [22,Lemma 3.5], [43] and [45,Theorem 2.9].
Lemma 4.6. Set ˆQt to be the solution map of system (2.12) on the spaceE2, i.e., ˆQt(ˉφ)=ut(ˉφ), for t≥0 and ∀ˉφ∈E2. Thus, ˆQt is an ω-periodic semiflow on E2, in this sense, one has
(i) ˆQ0=I;
(ii) ˆQt+ω=ˆQt∘ˆQω, ∀t≥0;
(iii) ˆQt(ˉφ) is continuous in (t,ˉφ)∈[0,∞)×E2.
Furthermore, ˆQ:=ˆQω admits a strong global attractor in E2.
Next, we prove that the solution of system (2.12) is strictly positive.
Lemma 4.7. Use u(t,⋅,ˉφ)=(u1(t,⋅,ˉφ),u2(t,⋅,ˉφ),u3(t,⋅,ˉφ)) to be the solution of (2.12) with the initial data u0=ˉφ∈E2, if there is t1≥0 such that u2(t1,⋅,ˉφ)≢0, andu3(t1,⋅,ˉφ)≢0, in that way, the solution of system (2.12) meets
u2(t,x,ˉφ)>0,u3(t,x,ˉφ)>0,∀t>t1,x∈ˉΩ. | (4.6) |
Besides, for ∀t>0, x∈ˉΩ and any initial data ˉφ∈E2, one has u1(t,x,ˉφ)>0, and
lim inft→∞u1(t,x,ˉφ)≥ε,unifromlyforx∈ˉΩ, | (4.7) |
where ε>0 is a ˉφ-independent positive constant.
Proof. According to the comparison principle for cooperative systems, we have u2(t,x)≥0 and u3(t,x)≥0 for t>0 and x∈ˉΩ. Moreover, for a fixed ˉφ∈E2, it is easy to know that u2(t,x,ˉφ) and u3(t,x,ˉφ) satisfy
{∂u2∂t≥DvΔu2−ˆμvu2,∂u3∂t≥DhΔu3−(ˆμh+ˆϱ)u3,∂u2∂ν=∂u3∂ν=0,x∈∂Ω, |
where ˆμv=maxt∈[0,ω],x∈ˉΩμ(t,x), ˆμh=maxx∈ˉΩμh(x) and ˆϱ=maxx∈ˉΩϱ(x). If there exists t1≥0, such that u2(t1,⋅,ˉφ)≠0 and u3(t1,⋅,ˉφ)≠0, one has u2(t,⋅,ˉφ)>0 and u3(t,⋅,ˉφ)>0, ∀t>t1 based on the strong maximum principle [40,Proposition 13.1]. For t>0, let ˉn(t,x,ˉφ2) be the solution of
{∂ˉn(t,x)∂t=DvΔˉn(t,x)+(1−τ′1(t))Λv(t−τ1(t),x)e−∫tt−τ1(t)μm(r,x)dr−(αβ(t,x)pl+μv(t,x))ˉn(t,x),x∈Ω,∂ˉn(t,x)∂ν=0,x∈∂Ω. | (4.8) |
Clearly, Λv(t,x)≢0 is non-negative non-trivial and Hölder continuous on R×ˉΩ. Using the comparison principle, one has
u1(t,x)≥ˉn(t,x)>0,t>0,x∈ˉΩ. |
In addition, from reference [38,Lemma 2.1], system (4.8) allows a unique globally attractive periodic solution ˉn∗(t,⋅). Then
lim inft→∞u1(t,x,ˉφ1)≥ε:=mint∈[0,ω],x∈ˉΩˉn∗(t,x),uniformlyforx∈ˉΩ. |
This proof is complete.
For every fixed ˉφ∈E2, u(t,x,ˉφ) is the unique solution of system (2.12) with u0=ˉφ. The following conclusion indicates that R0 is a threshold for the transmission of disease.
Theorem 4.8. Let R0 be defined in (4.4).We have the following statements:
(i) When R0<1, the disease-free ω-periodic solution (u∗1(t,x),0,0) of system (2.12) is globally attractive.
(ii) When R0>1, system (2.12) has at least one positive ω-periodic solution (ˉz∗1(t,x),ˉz∗2(t,x),ˉz∗3(t,x)), and there exists a constant ˉσ>0such that for every ˉφ∈E2 withˉφ2(⋅)≢0, ˉφ3(0,⋅)≢0, on has
lim inft→∞minx∈ˉΩui(t,x,ˉφ)≥ˉσ,i=1,2,3. | (4.9) |
Proof. Since ˆQt is the solution map of system (2.12) on E2, based on reference [22,Lemma 3.5], ˆQt is an ω-periodic semiflow of system (2.12). Thence, ˆQ:=ˆQω is the Poincaré map, and {ˆQn}n≥0 is a discrete-time system on E2. For every fixed ˉφ∈E2, the omega limit set of the orbit {ˆQn(ˉφ)}n≥0 is ω(ˉφ). Then ω(ˉφ) is an internally chain transitive set for {ˆQn} on E2.
(i) As R0<1, according to Lemma 4.4, one has r(˜Q)<1, and therefore ˜μ=lnr(˜Q)ω<0. For t>0, discuss the following system with parameter ϵ>0,
{∂wϵ1∂t=DvΔwϵ1−μv(t,x)wϵ1+(1−τ′2(t))∫ΩΓ(t,t−τ2(t),x,y)αβ(t−τ2(t),y)p[u∗1(t−τ2(t),y)+ϵ]wϵ2(t−τ2(t),y)lN(y)dy,x∈Ω,∂wϵ2∂t=DhΔwϵ2+cβ(t,x)wϵ1−(μh(x)+ϱ(x))wϵ2,x∈Ω,∂wϵ1∂ν=∂wϵ2∂ν=0,x∈∂Ω. | (4.10) |
Denote wϵ(t,x,ˆφ)=(wϵ1(t,x,ˆφ),wϵ2(t,x,ˆφ)) to be the unique solution of system (4.10) for any ˆφ∈E1, with wϵ0(ˆφ)(θ,x)=(ˆφ(0,x),ˆφ(θ,x)) for all θ∈[−τ2(0),0], x∈ˉΩ, where
wϵt(ˆφ)(θ,x)=wϵ(t+θ,x,ˆφ)=(wϵ1(t,x,ˆφ),wϵ2(t+θ,x,ˆφ)),θ∈[−τ2(0),0],∀t≥0,x∈ˉΩ. |
Let ˜Qϵt:=E1→E1 be the solution map of system (4.10) and ˜Qϵ:=˜Qϵω be the corresponding Poincaré map, i.e., ˜Qϵ(ˆφ)=wϵω(ˆφ), for ∀ˆφ∈E1, and make r(˜Qϵ) be the spectral radius of ˜Qϵ. Then the eventual strong monotonicity and compactness of ˜Qϵ on are easy to prove, for . From the continuity of the principle eigenvalue to parameters, one has . Allow to be small enough, one has . From Lemma 4.5, a positive -periodic function exists such that is a solution of system (4.10), where . By system (4.1), is globally attractive and the comparison principle, there must be a large enough integer such that and
Thus, as , one has
(4.11) |
there exists some , for any given , such that
Using systems (4.10) and (4.11), and the comparison theorem [36,Proposition 1], we have
Accordingly, uniformly for . Using the theory of internally chain transitive sets [32,Section 1.2], we can prove that uniformly for , where is a globally attractive solution of system (4.1). Based on the above argument, meets a non-autonomous system, and this system tends to periodic system (4.1) asymptotically. It is known that system (4.1) can produce a solution semiflow , on . Then is a Poincaré map related to system (4.1). Obviously, has a global attractor in .
Let be the omega limit set of for . Owing to and uniformly for , one has . Here, represents function which is identical to , i.e., , . Following Lemma 4.7, we have . Based on [32,Lemma 1.2.1], we know that is an internally chain transitive set for , then is an internally transitive chain set for . Define by for . Since and is globally attractive in , one has , where is the stable set of . According to [32,Lemma 1.2.1], one has . is proved, thence
(ii) When , Lemmas 4.1, 4.4 and 4.5 indicate , consequently, . Let
and
For every , Lemma 4.7 reveals that and , , . Thus, , . Lemma 4.6 evidences that has a strong global attractor in .
Set
and the omega limit set of the orbit is . Denote . Next, we prove that cannot form a cycle for in .
Claim 1. For every , the omega limit set .
For every fixed , , . Then either or , for each . Furthermore, by contradiction and Lemma 4.7, it is obvious that for each , either or . If for , then uniformly for . Thereby, the equation in system (2.12) meets
where and . According to the comparison principle, one has uniformly for . Suppose that for some , in the light of Lemma 4.7, we obtain , . Accordingly, . From the equation in system (2.12), one has uniformly for . Consequently, the equation in system (2.12) abides by a nonautonomous system, which is asymptomatic to the periodic system (4.1). The theory of asymptomatically periodic system [32,Section 3.2] implies that uniformly for . Therefore, for any , and can not form a cycle for in .
For , study the time-periodic parabolic system with parameter
(4.12) |
For every , set to be the unique solution of system (4.12) with for all , , where
for any and . Let be the solution map of system (4.12), i.e., , and be the corresponding Poincaré map, for . Let be the spectral radius of . Because , a fully small can be selected, such that
For the certain , according to the continuous dependence of the solution on the initial data, there must be a constant such that for all with , which leads to for all .
Claim 2. For any , then .
Assuming for some , one has , by contradiction. So there is such that for all . For each , set with and , one has
(4.13) |
Following system (4.13) and Lemma 4.7, we can receive
for each , and . As , and meet
(4.14) |
Based on for every and , there must be a constant , such that
where is a positive -periodic function and is a solution of system (4.12), then . By system (4.14) and the comparison theorem
Obviously, , then and as , which leads to a contradiction.
With the above claim, it is easy to obtain that is an isolated invariant set for in , and , where is the stable set of for . For every integer and , is compact, then is compact, and is asymptotically smooth on . Moreover, similar to Lemma 4.6, we get that has a global attractor on . According to reference [45,Theorem 3.7], has a global attractor in . Based on the acyclicity theorem on uniform persistence for map [32,Theorem 1.3.1 and Remark 1.3.1], we obtain that is uniformly persistent with respect to , in this sense, there exists an , such that
(4.15) |
Now, the practical persistence are derived. Following , we obtain that and for any . Set . Obviously, we have and , . The continuous function is defined by
Because is a compact subset of , we obtain that . Consequently, there is an such that
Furthermore, according to Lemma 4.7, there must be an such that
By references [29,Lemma 8] and [32,Theorem 3.5.1], for every , the solution map of system (2.12), defined in Lemma 3.2, is a -contraction about an equivalent norm on , where is Kuratowski measure of noncompactness. Define
and
For any , is -uniformly persistent with is easily attainable. It then follows from [45,Theorem 4.5], applicable to , that system (2.12) has an -periodic solution with . Let , and where . Combing the uniqueness of solutions and Lemma 4.7, we have that is periodic solution system (2.12) and it is also strictly positive.
Next, we prove the asymptomatic behaviour of and in system (2.11). By Eq (2.6), and is nonnegative and Hölder continuous function for and . Then there is a unique positive -periodic solution which is globally attractive. From Eq (3.6) and Theorem 4.8(i), when , one has . With the arguments similar to those above, we can prove that if , then and , uniformly for . By Eq (2.12), Theorem (4.8)(ii) and Eqs (2.6) and (3.6), then if , for any with and , one has
uniformly for . Since is Hölder continuous and non-negative function for and from Eq (2.6), then there exists such that
uniformly for with satisfies compatibility condition (3.4). By the integral form Eq (3.6), then exists such that
with satisfies compatibility condition (3.5). In addition, if is -periodic in , then is -periodic is easy to be checked. Therefore, the following result is obtained.
Theorem 4.9. Let be defined as in (4.4).Set to be the solution of system (2.11) with , where.One has:
(i) When , the disease-free -periodic solution of system (2.11) is globally attractive.
(ii) When , system (2.11) has at least one positive -periodic solution , where , , and there is a constantthat makes for every with, , we have
(4.16) |
In this part, we use numerical simulations to clarify the impact of spatial heterogeneity, periodic delays, seasonality, and vector-bias on the spread of malaria, to show how to derive some understanding of epidemiology from our analysis results.
Here, some simulations to support the analysis results built in Section 4 are provided. More precisely, the potential dynamics outcomes of system (2.11) are given. For convenience, we will focus our attention on the domain , which is one-dimensional, denoted by to simulate the long-time behavior of system (2.11). The basic reproduction number often (but not always) controls the extinction and persistence of the disease. Specifically, system (2.11) applies to the transmission of malaria in Maputo Province, Mozambique, a sub-Saharan African country where malaria is at risk of spreading in the country. The WHO report shows that the number of confirmed malaria cases has been increasing in recent years, and the condition deteriorated severely in 2014.
According to reference [24], suppose the total population density . The unit of time is month. Set the periodic months. We set , where means that people living in urban areas (near the center area) can get better medical services (number of doctors and hospitals, advanced medical equipment, supply of medicines) than people in rural areas. This results in a higher recovery rate near the center. See Appendix E for the values and definitions of other parameters.
To compute , we use the numerical method proposed in reference [41,Lemma 2.5 and Remark 3.2]. Using the above parameters set, the basic reproduction number can be numerically calculate as , which implies that in mosquito and human populations, the disease persist. Figure 3 shows numerical plots of humans and mosquitoes compartments with initial data
where . This conforms to the conclusion of Theorem 4.9(ii). The time interval can be truncated [20,30] to prove that the existence of the positive periodic solution.
Reduce the bite rate to , and increase the death rate of mosquito to , which can be achieved by using insecticide-treated nets, then . Thus, immature mosquitoes and susceptible adult mosquitoes show periodic fluctuations. The exposed adult mosquitoes, infectious adult mosquitoes and infectious humans converge to 0 (Figure 4). This is coincident with the conclusion of Theorem 4.9(i).
We are interested in how system parameters affect the disease risk . In this section, we choose the parameters that are consistent with those in Section 5.1.
In this subsection, we explore the impact of mature period affected by seasonal climate change on malaria transmission. The results are given in Figure 5, the green one represents the time-averaged value of maturation delay in system (2.11), where and the red one indicates system (2.11) is under a time-periodic maturation delay. An intuitive result is that in these four cases, the green line is always below the red line, which fully indicates that the time-average maturity delay will underestimate the risk of malaria transmission, so the impact of climate change cannot be ignored. In the following subsections, we analyze in detail the sensitivity of to these four parameters.
Looking at Figure 5, we let vary in , and other parameters are same as those in Figure 3 and explore the impact of the vector-bias effect, are used to represent the relative attractiveness of susceptible to infected humans. From Figure 5(a), it can be easily seen that is an increasing function of . Therefore, ignoring the vector-bias effect will ultimately underestimate the risk of disease transmission. And this conclusion is valid regardless of whether the periodic or the time-average maturation delay is considered.
In this subsection, we examine the impact of interventions on . Note that in Figure 3(e), the population density of infected individuals in urban (central) areas is less than in rural (border) areas, which prompts us to explore the relationship between human recovery rate and disease risk in a heterogeneous space. Since medical resources (advanced medical equipment, the number of hospitals and doctors, medicine supply) are abundant in urban areas than in rural areas, humans can get better medical services in urban areas with a higher recovery rate.
In this subsection, we analyze the impact of medical resources on the spread of malaria, including two aspects: (i) the impact of increasing medical resources; (ii) for fixed medical resources, the impact of different allocation measures on disease transmission. In Figure 5(b), we let in vary in , and the other parameters are same as those in Figure 3. It proposes a strategy, i.e., in the current allocation of the medical resources, the recovery rate can be improved through efforts to develop new drugs. Figure 5(b) shows that increasing medical resources can reduce to less than 1, which means that the disease can be controlled. In this paper, we use the recovery rate of the entire region to represent medical resources.
In the case of fixed medical resources, we explore the impact of different allocation on the spread of disease. Choose and a new parameter is added to , i.e., , where , which measures the difference in the allocation of urban and rural medical resources. Other parameters are the same as those in Figure 3. When , the gap between rural and urban medical resources is the largest, and the recovery rate in urban area is the highest (near the center of space area, i.e., ). As changes from 0 to 1, medical resources are allocated to nearby rural area (near and ), and the gap in medical conditions between rural and urban areas gradually narrows, and is eventually evenly distributed in space. Through calculation, it can be found that if , in order to make less than 1, is needed, but if , the medical resources only need 0.0576, which can make . From Figure 5(c), we come to an interesting conclusion that in the case of limited medical resources, the spatial heterogeneity of the distribution of medical resources increases the risk of disease transmission. This result indicates that the distribution of medical resources dose play an important role in the design of malaria control programs.
We explore the impact of human mobility on the transmission of malaria in a heterogeneous space. Let vary in and other parameters are consistent with those in Figure 3. The result is shown in Figure 5(d), which describes the relationship between and . It can be directly observed from Figure 5(d) that decreases with respect to . When is very small, will drop sharply and as continues to increase, the rate of decline of will slow down. This seems to indicate that malaria cannot be controlled if no protective measures are taken and only by improving a high diffusion to avoid mosquito bites without taking any protective measures [49] systematically analyzes this problem.
In Section 5.2.4, we explore the impact of diffusion on , and study the impact of diffusion on the final size of disease transmission. Set and other parameters are consistent with those in Figure 3. When and , calculate , the disease is extinct. However, without considering the movement of mosquitoes and humans, that is, when the diffusion coefficients are and , it is found that is greater than 1, and the disease is persistent. Then, we will get the result shown in Figure 6, which shows some interesting phenomena. Under this set of parameters, if the diffusion of mosquitoes and humans is not considered, then the disease is extinct in urban areas, and is persistent in rural areas. The reason for this result is that we study spatial heterogeneity. Due to urban environment is not suitable for mosquitoes to survive, the number of mosquitoes is relatively small, and the medical resources are relatively large, so the urban disease control is better. Compared with the right column of Figure 6, the movement of mosquitoes and humans will reduce the risk of disease transmission to a certain extent, which is consistent with the conclusions in Figure 5(d) and reference [24]. There are two explanations: (i) The existence of diffusion indicates that the infected humans in rural areas can be treated in cities with better medical conditions. (ii) As mentioned in reference [24], to a certain extent, it is difficult for mosquitoes to take a blood meal among moving humans.
As we all know, in the study of malaria transmission, the combined effects of temperature-dependent EIP and maturation delay, vector-bias, spatial structure and seasonal variation are worth studying. Here, we establish and analyze a reaction-diffusion model of malaria, including periodic delays and vector-bias in a heterogeneous environment.
Using the theory proposed by Liang et al. [41] and Zhao [42], the basic reproduction number can be introduced. We first prove that in a defined phase space, linear system (4.2) generates a periodic semiflow which is eventually strongly monotonic. Then, we describe as a threshold for the extinction and persistence of malaria. It is proved that if , then malaria will be eliminated. When , there admits at least one positive -periodic solution.
In the numerical part, data for exploring the transmission of malaria in Maputo Provence, Mozambique have been published. The numerical simulation is divided into three parts. First, we give some simulation conclusions to support the theoretical analysis. Second, we discuss the sensitivity of to the parameters in the model. (I) Our numerical results show that if we only consider the time-average maturation delay, we can underestimate the risk of malaria transmission assessed by . (II) It is easy to know that is decreasing with respect to . Thence, if the impact of vector-bias effect on malaria transmission is ignored, the risk of transmission will be underestimated. (III) We analyze the impact of intervention measures on from two aspects: (i) the impact of increasing medical resources. This case is mainly due to the uneven distribution of medical resources in rural and urban areas, which increases the impact of medical resources on ; (ii) for fixed medical resources, the impact of different allocation measures on disease transmission. Through the analysis of this case, we find that in the case of limited medical resources, narrowing the gap in the allocation of medical resources between rural and urban areas can better reduce the risk of malaria transmission. Third, we explore the impact of diffusion on in a spatially heterogeneous environment, assuming that the distribution of medical resources and the initial data of mosquitoes and humans depend on space. Biologically speaking, we understand this spatial heterogeneity as the difference between rural and urban areas. In addition, we also study the impact of diffusion on the final size of malaria. We find that under the set parameters, if the diffusion of mosquitoes and humans is not considered, the disease will become extinct in urban areas, and persist in rural areas. But under this set of parameters, the disease will become extinct if the diffusion is not considered.
We are very grateful to anonymous referees and editor for careful reading and helpful suggestions which led to an improvement of our original manuscript. The authors are grateful for the support and useful comments provided by Professor Xiaoqiang Zhao (Memorial University of Newfoundland). This research is supposed by National Natural Science Foundation of China (grant number: 11971013) and Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX) and Nanjing University of Aeronautics and Astronautics PhD short-term visiting scholar project (ZDGB2021027).
The authors declare there is no conflict of interest.
Proof. Firstly, the local existence of the unique mild solution is proved. Clearly, is locally Lipschitz continuous. It is necessary to show
(A.1) |
For all and , because , one has
for and , where and , and
This implies that
Consequently, by reference [36,Corollary 4] with and , system (2.12) has a unique mild solution on its maximum existence interval and where , . In addition, when , is a classical solution, based on the analyticity of , and .
Analyze the following time-periodic reaction-diffusion equation
(A.2) |
By reference [38,Lemma 2.1], system (A.2) has a unique globally attractive positive -periodic solution in . Since system (A.2) can dominate the first equation of (2.12), there is a such that for any , a positive integer exists and meets for all and .
Next, similar to reference [46,Theorem 2.1], the ultimate boundedness of solutions can be proved. Set
for any , let , , , and where . Using the Green's formula and integrating the first equation of system (2.12), one has
that is,
(A.3) |
By system (A.3), the property of the fundamental solutions [47] and Green's formula, the second equation of (2.12) are integrated to get
(A.4) |
where , and are positive numbers independent of . Select in system (15.4), so that
which yields for , where is some integer. Hence,
Integrating the third equation on model (2.12), and applying Green's formula, we have
Thus,
for , and . Therefore, we have for each .
Let be a family of operators on and for , , and . Similar to the proof of Lemma 2.1 in reference [38], we can show that is an -periodic semiflow on . From the above proofs, we conclude that is point dissipative. Moreover is -contraction, where is Kuratowski measure of noncompactness, and hence, is asymptotically smooth. By references [48,Theorem 2.4.7] and [32,Theorem 1.1.2], it follows that has a global compact attractor.
Proof. Let . For all , since strictly increase with respect to , one has
and therefore, . Thus, for any , there holds
Fix , for , the solution of the above linear system exists uniquely. To put this another way, one has , where and , .
By repeating the above step to , we see that the solution with initial date exists uniquely for all .
Proof. Similar to the proof of Lemma 4.2, on each interval , , one easily obtain that , () for all . Select a , such that for every , is strictly increasing with respect to , and is increasing in . Then, for , both and meet the following system
Therefore, for a fixed , one has
(C.1) |
where are evolution operators related to and with Nuemann boundary condition. Since are increasing in , it easily follows that . Generally, we assume that . Then there exists an such that . According to the equation of (17.1), we have for all . If , then . It is easy to know that , for all according to the second equation of (17.1). This means that there is for all , , so the solution map is strongly positive for all .
Proof. For every , let be the solution of (4.2) with . Since , we get for all will be a piece of cake. Denote
Then for , , and meets the linear-periodic system with
(D.1) |
for . Hence, for all , , is the solution of the -periodic system (D.1) with , where for each with
For every , , one has
Consequently, for all , and by the existence and uniqueness of system (D.1), one has
Thus, is an -periodic solution of (D.1) and is a solution of (4.2).
The authors in reference [20] discussed the impact of seasonality on the spread of malaria including assessing the seasonal related bite rate , periodic maturity delay , periodic EIP , periodic death and recruitment rate of mosquitoes, where
(E.1) |
(E.2) |
(E.3) |
(E.4) |
(E.5) |
(E.6) |
Other parameter values are defined as
Parameter | Definition | Value(range) | References |
Total human population number | 53 | [24] | |
Natural mortality rate of humans | 0.00157 | [20] | |
Constant recovery rate of humans | (0.04256, 0.5168) | [24] | |
Vector-bias parameter | [13] | ||
Transmission probability | (0.01, 0.27) | [50] | |
from infectious mosquitoes to humans | |||
Diffusion rate of humans | 0.1 | [24] | |
Diffusion rate of mosquitoes | 0.0125 | [24] | |
Transmission probability from | (0.072, 0.64) | [50] | |
infectious humans to mosquitoes per bite | |||
Biting rate of mosquitoes | (E.1) | [20] | |
Death rate of mosquitoes | (E.4) | [20] | |
Maturation delay of | (E.2) | [51] | |
mosquitoes in the aquatic stage | |||
EIP of mosquitoes | (E.3) | [24] | |
Recruitment rate of mosquitoes | (E.5) | [24] | |
Natural death rate for the aquatic stage | (E.6) | [52] |
[1] | Kochanek KD, Murphy SL, Xu JQ, et al. (2024) Mortality in the United States, 2022. NCHS Data Brief, no 492 . Hyattsville, MD: National Center for Health Statistics. 2024. https://dx.doi.org/10.15620/cdc:135850. |
[2] | Global Cancer Observatory, World Health Organization, Colon and Rectum. Accessed 12 March 2024. Available from: https://gco.iarc.fr/today/en/fact-sheets-cancers |
[3] |
Bray F, Laversanne M, Sung H, et al. (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74: 229-263. https://doi.org/10.3322/caac.21834 ![]() |
[4] | Ferlay J, Ervik M, Lam F, et al. (2024) Global Cancer Observatory: Cancer Today (version 1.1). Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today. |
[5] |
Morgan E, Arnold M, Gini A, et al. (2023) Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72: 338-344. https://doi.org/10.1136/gutjnl-2022-327736 ![]() |
[6] |
Sullivan BA, Noujaim M, Roper J (2022) Cause, epidemiology, and histology of polyps and pathways to colorectal cancer. Gastrointest Endosc Clin N Am 32: 177-194. https://doi.org/10.1016/j.giec.2021.12.001 ![]() |
[7] |
Nguyen LH, Goel A, Chung DC (2020) Pathways of colorectal carcinogenesis. Gastroenterology 158: 291-302. https://doi.org/10.1053/j.gastro.2019.08.059 ![]() |
[8] |
Simon K (2016) Colorectal cancer development and advances in screening. Clin Interv Aging 11: 967-976. https://doi.org/10.2147/CIA.S109285 ![]() |
[9] |
Pickhardt PJ, Kim DH (2009) Colorectal cancer screening with CT colonography: key concepts regarding polyp prevalence, size, histology, morphology, and natural history. AJR Am J Roentgenol 193: 40-46. https://doi.org/10.2214/AJR.08.1709 ![]() |
[10] |
Pino MS, Chung DC (2010) The chromosomal instability pathway in colon cancer. Gastroenterology 138: 2059-2072. https://doi.org/10.1053/j.gastro.2009.12.065 ![]() |
[11] |
Powell SM, Zilz N, Beazer-Barclay Y, et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359: 235-237. https://doi.org/10.1038/359235a0 ![]() |
[12] |
Rim EY, Clevers H, Nusse R (2022) The Wnt pathway: from signaling mechanisms to synthetic modulators. Annu Rev Biochem 91: 571-598. https://doi.org/10.1146/annurev-biochem-040320-103615 ![]() |
[13] |
Dienstmann R, Connor K, Byrne AT (2020) COLOSSUS consortium. Precision therapy in RAS mutant colorectal cancer. Gastroenterology 158: 806-811. https://doi.org/10.1053/j.gastro.2019.12.051 ![]() |
[14] |
Fernández-Medarde A, Santos E (2011) Ras in cancer and developmental diseases. Genes Cancer 2: 344-358. https://doi.org/10.1177/1947601911411084 ![]() |
[15] |
Simanshu DK, Nissley DV, McCormick F (2017) RAS proteins and their regulators in human disease. Cell 170: 17-33. https://doi.org/10.1016/j.cell.2017.06.009 ![]() |
[16] |
Zhu G, Pei L, Xia H, et al. (2021) Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Mol Cancer 20: 143. https://doi.org/10.1186/s12943-021-01441-4 ![]() |
[17] |
McLellan EA, Owen RA, Stepniewska KA, et al. (1993) Lemoine NR. High frequency of K-ras mutations in sporadic colorectal adenomas. Gut 34: 392-396. https://doi.org/10.1136/gut.34.3.392 ![]() |
[18] |
Naccarati A, Polakova V, Pardini B, et al. (2012) Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer. Mutagenesis 27: 211-218. https://doi.org/10.1093/mutage/ger067 ![]() |
[19] |
Fischer M (2017) Census and evaluation of p53 target genes. Oncogene 36: 3943-3956. https://doi.org/10.1038/onc.2016.502 ![]() |
[20] |
Lin D, Shields MT, Ullrich SJ, et al. (1992) Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc Natl Acad Sci USA 89: 9210-9214. https://doi.org/10.1073/pnas.89.19.9210 ![]() |
[21] |
Engeland K (2022) Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ 29: 946-960. https://doi.org/10.1038/s41418-022-00988-z ![]() |
[22] |
Iacopetta B, Russo A, Bazan V, et al. (2006) Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol 217: 842-847. https://doi.org/10.1093/annonc/mdl035 ![]() |
[23] |
Leslie A, Carey FA, Pratt NR (2002) The colorectal adenoma-carcinoma sequence. Br J Surg 89: 845-860. https://doi.org/10.1046/j.1365-2168.2002.02120.x ![]() |
[24] |
Westra JL, Schaapveld M, Hollema H, et al. (2005) Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients. J Clin Oncol 23: 5635-5643. https://doi.org/10.1200/JCO.2005.04.096 ![]() |
[25] |
Söreide K, Janssen EA, Söiland H, et al. (2006) Microsatellite instability in colorectal cancer. Br J Surg 93: 395-406. ![]() |
[26] | De' Angelis GL, Bottarelli L, Azzoni C, et al. (2018) Microsatellite instability in colorectal cancer. Acta Biomed 89: 97-101. https://doi.org/10.23750/abm.v89i9-S.7960 |
[27] | Parsons R, Li GM, Longley MJ, et al. (1993) Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75: 1227-1236. https://doi.org/10.1016/0092-8674(93)90331-j |
[28] |
Hendriks YM, de Jong AE, Morreau H, et al. (2006) Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin 56: 213-225. https://doi.org/10.3322/canjclin.56.4.213 ![]() |
[29] |
Iacopetta B, Grieu F, Amanuel B (2010) Microsatellite instability in colorectal cancer. Asia Pac J Clin Oncol 6: 260-269. https://doi.org/10.1111/j.1743-7563.2010.01335.x ![]() |
[30] |
Sninsky JA, Shore BM, Lupu GV (2022) Crockett SD. Risk factors for colorectal polyps and cancer. Gastrointest Endosc Clin N Am 32: 195-213. https://doi.org/10.1016/j.giec.2021.12.008 ![]() |
[31] |
Lewandowska A, Rudzki G, Lewandowski T (2022) Risk factors for the diagnosis of colorectal cancer. Cancer Control 29. https://doi.org/10.1177/10732748211056692 ![]() |
[32] |
Betesh AL, Schnoll-Sussman FH (2021) Colorectal cancer screening in the elderly. Clin Geriatr Med 37: 173-183. https://doi.org/10.1016/j.cger.2020.08.012 ![]() |
[33] | Gupta S (2022) Screening for colorectal cancer. Hematol Oncol Clin North Am 36: 393-414. https://doi.org/10.1016/j.hoc.2022.02.001 |
[34] |
Mehraban Far P, Alshahrani A, Yaghoobi M (2019) Quantitative risk of positive family history in developing colorectal cancer: A meta-analysis. World J Gastroenterol 25: 4278-4291. https://doi.org/10.3748/wjg.v25.i30.4278 ![]() |
[35] | Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, et al. (2017) Colorectal carcinoma: A general overview and future perspectives in colorectal cancer. Int J Mol Sci 18: 197. https://doi.org/10.3390/ijms18010197 |
[36] |
Siegel RL, Torre LA, Soerjomataram I, et al. (2019) Global patterns and trends in colorectal cancer incidence in young adults. Gut 68: 2179-2185. https://doi.org/10.1136/gutjnl-2019-319511 ![]() |
[37] |
Bailey CE, Hu CY, You YN, et al. (2015) Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg 150: 17-22. https://doi.org/10.1001/jamasurg.2014.1756 ![]() |
[38] |
O'Sullivan DE, Sutherland RL, Town S, et al. (2022) Risk factors for early-onset colorectal cancer: A systematic review and Meta-analysis. Clin Gastroenterol Hepatol 20: 1229-1240.e5. https://doi.org/10.1016/j.cgh.2021.01.037 ![]() |
[39] |
Ionescu VA, Gheorghe G, Bacalbasa N, et al. (2023) Colorectal cancer: from risk factors to oncogenesis. Medicina 59: 1646. https://doi.org/10.3390/medicina59091646 ![]() |
[40] |
Zhou X, Wang L, Xiao J, et al. (2022) Alcohol consumption, DNA methylation and colorectal cancer risk: Results from pooled cohort studies and Mendelian randomization analysis. Int J Cancer 151: 83-94. https://doi.org/10.1002/ijc.33945 ![]() |
[41] |
Farvid MS, Sidahmed E, Spence ND, et al. (2021) Consumption of red meat and processed meat and cancer incidence: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol 36: 937-951. https://doi.org/10.1007/s10654-021-00741-9 ![]() |
[42] |
Ladabaum U, Dominitz JA, Kahi C, et al. (2020) Strategies for colorectal cancer screening. Gastroenterology 158: 418-432. https://doi.org/10.1053/j.gastro.2019.06.043 ![]() |
[43] |
Wu Z, Li Y, Zhang Y, et al. (2020) Colorectal cancer screening methods and molecular markers for early detection. Technol Cancer Res Treat 19: 1533033820980426. https://doi.org/10.1177/1533033820980426 ![]() |
[44] |
Schreuders EH, Ruco A, Rabeneck L, et al. (2015) Colorectal cancer screening: a global overview of existing programmes. Gut 64: 1637-1649. https://doi.org/10.1136/gutjnl-2014-309086 ![]() |
[45] |
Shaukat A, Levin TR (2022) Current and future colorectal cancer screening strategies. Nat Rev Gastroenterol Hepatol 19: 521-531. https://doi.org/10.1038/s41575-022-00612-y ![]() |
[46] |
Potter NT, Hurban P, White MN, et al. (2014) Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem 60: 1183-1191. https://doi.org/10.1373/clinchem.2013.221044 ![]() |
[47] |
Cohen JD, Li L, Wang Y, et al. (2018) Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359: 926-930. https://doi.org/10.1126/science.aar3247 ![]() |
[48] |
Barnell EK, Wurtzler EM, La Rocca J, et al. (2023) Multitarget stool RNA test for colorectal cancer screening. JAMA 330: 1760-1768. https://doi.org/10.1001/jama.2023.22231 ![]() |
[49] |
Mahmoud NN (2022) Colorectal cancer: preoperative evaluation and staging. Surg Oncol Clin N Am 31: 127-141. https://doi.org/10.1016/j.soc.2021.12.001 ![]() |
[50] |
Nagtegaal ID, Quirke P, Schmoll HJ (2011) Has the new TNM classification for colorectal cancer improved care?. Nat Rev Clin Oncol 9: 119-123. https://doi.org/10.1038/nrclinonc.2011.157 ![]() |
[51] |
Chen K, Collins G, Wang H, et al. (2021) Pathological features and prognostication in colorectal cancer. Curr Oncol 28: 5356-5383. https://doi.org/10.3390/curroncol28060447 ![]() |
[52] |
Carlsen L, Huntington KE, El-Deiry WS (2022) Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. Cancers 14: 1028. https://doi.org/10.3390/cancers14041028 ![]() |
[53] |
Zhao W, Jin L, Chen P, et al. (2022) Colorectal cancer immunotherapy-Recent progress and future directions. Cancer Lett 545: 215816. https://doi.org/10.1016/j.canlet.2022.215816 ![]() |
[54] |
Shinji S, Yamada T, Matsuda A, et al. (2022) Recent Advances in the Treatment of Colorectal Cancer: A Review. J Nippon Med Sch 89: 246-254. ![]() |
[55] |
Merchant J, McArthur D, Ferguson H, et al. (2021) Concepts and prospects of minimally invasive colorectal cancer surgery. Clin Radiol 76: 889-895. https://doi.org/10.1016/j.crad.2021.09.013 ![]() |
[56] | Vilsan J, Maddineni SA, Ahsan N, et al. (2023) Open, Laparoscopic, and Robotic Approaches to Treat Colorectal Cancer: A Comprehensive Review of Literature. Cureus 15: e38956. https://doi.org/10.7759/cureus.38956 |
[57] |
Zhang M, Liu Z, Wang X (2022) Is natural orifice specimen extraction surgery the future direction of minimally invasive colorectal surgery?. Surg Open Sci 10: 106-110. https://doi.org/10.1016/j.sopen.2022.08.001 ![]() |
[58] |
Song XJ, Liu ZL, Zeng R, et al. (2019) A meta-analysis of laparoscopic surgery versus conventional open surgery in the treatment of colorectal cancer. Medicine 98: e15347. https://doi.org/10.1097/MD.0000000000015347 ![]() |
[59] |
Luo W, Wu M, Chen Y (2022) Laparoscopic versus open surgery for elderly patients with colorectal cancer: a systematic review and meta-analysis of matched studies. ANZ J Surg 92: 2003-2017. https://doi.org/10.1111/ans.17972 ![]() |
[60] |
Yang L, Fang C, Bi T, et al. (2023) Efficacy of robot-assisted vs. laparoscopy surgery in the treatment of colorectal cancer: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 47: 102176. https://doi.org/10.1016/j.clinre.2023.102176 ![]() |
[61] |
Huang Z, Huang S, Huang Y, et al. (2023) Comparison of robotic-assisted versus conventional laparoscopic surgery in colorectal cancer resection: a systemic review and meta-analysis of randomized controlled trials. Front Oncol 13: 1273378. https://doi.org/10.3389/fonc.2023.1273378 ![]() |
[62] |
Zhao Z, Gu J (2022) Open surgery in the era of minimally invasive surgery. Chin J Cancer Res 34: 63-65. https://doi.org/10.21147/j.issn.1000-9604.2022.01.06 ![]() |
[63] |
Biller LH, Schrag D (2021) Diagnosis and treatment of metastatic colorectal cancer: A review. JAMA 325: 669-685. https://doi.org/10.1001/jama.2021.0106 ![]() |
[64] | European Medicines AgencyHomepage. Accessed March 8, 2025. Available from: https://www.ema.europa.eu/en/homepage |
[65] | National Cancer InstituteColorectal cancer treatment drugs. Accessed March 8, 2025. Available from: https://www.cancer.gov/about-cancer/treatment/drugs/colorectal |
[66] |
Kuipers EJ, Grady WM, Lieberman D, et al. (2015) Colorectal cancer. Nat Rev Dis Primers 1: 15065. https://doi.org/10.1038/nrdp.2015.65 ![]() |
[67] |
Glimelius B, Stintzing S, Marshall J, et al. (2021) Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone. Cancer Treat Rev 98: 102218. https://doi.org/10.1016/j.ctrv.2021.102218 ![]() |
[68] |
Shin AE, Giancotti FG, Rustgi AK (2023) Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci 44: 222-236. https://doi.org/10.1016/j.tips.2023.01.003 ![]() |
[69] |
Colucci G, Gebbia V, Paoletti G, et al. (2005) Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol 23: 4866-4875. https://doi.org/10.1200/JCO.2005.07.113 ![]() |
[70] |
Nelson MA, Shetty S, Kulakodlu M, et al. (2011) A comparison of mortality and costs associated with FOLFOX versus FOLFIRI in stage IV colorectal cancer. J Med Econ 14: 179-186. https://doi.org/10.3111/13696998.2011.556693 ![]() |
[71] |
Van Cutsem E, Köhne CH, Hitre E, et al. (2009) Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 360: 1408-1417. https://doi.org/10.1056/NEJMoa0805019 ![]() |
[72] |
Douillard JY, Siena S, Cassidy J, et al. (2010) Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol 28: 4697-4705. https://doi.org/10.1200/JCO.2009.27.4860 ![]() |
[73] |
Itatani Y, Kawada K, Yamamoto T, et al. (2018) Resistance to anti-angiogenic therapy in Cancer-Alterations to Anti-VEGF Pathway. Int J Mol Sci 19: 1232. https://doi.org/10.3390/ijms19041232 ![]() |
[74] |
Diaz LA, Shiu KK, Kim TW, et al. (2022) Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. Lancet Oncol 23: 659-670. https://doi.org/10.1016/S1470-2045(22)00197-8 ![]() |
[75] |
Overman MJ, McDermott R, Leach JL, et al. (2017) Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol 18: 1182-1191. https://doi.org/10.1016/S1470-2045(17)30422-9 ![]() |
[76] |
Overman MJ, Lonardi S, Wong KYM, et al. (2018) Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol 36: 773-779. https://doi.org/10.1200/JCO.2017.76.9901 ![]() |
[77] |
Xie YH, Chen YX, Fang JY (2020) Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther 5: 22. https://doi.org/10.1038/s41392-020-0116-z ![]() |
[78] |
Saltz LB, Clarke S, Díaz-Rubio E, et al. (2008) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 26: 2013-2019. https://doi.org/10.1200/JCO.2007.14.9930 ![]() |
[79] |
Van Cutsem E, Tabernero J, Lakomy R, et al. (2012) Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. J Clin Oncol 30: 3499-3506. https://doi.org/10.1200/JCO.2012.42.8201 ![]() |
[80] | Siravegna G, Mussolin B, Buscarino M, et al. (2015) Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med 21: 795-801. https://doi.org/10.1038/nm.3870 |
[81] |
Goede V, Coutelle O, Neuneier J, et al. (2010) Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy. Br J Cancer 103: 1407-1414. https://doi.org/10.1038/sj.bjc.6605925 ![]() |
[82] |
Derangère V, Fumet JD, Boidot R, et al. (2016) Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?. Oncotarget 7: 9309-9321. https://doi.org/10.18632/oncotarget.7008 ![]() |
[83] |
André T, Shiu KK, Kim TW, et al. (2025) Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study. Ann Oncol 36: 277-284. https://doi.org/10.1016/j.annonc.2024.11.012 ![]() |
[84] |
Shan J, Han D, Shen C, et al. (2022) Mechanism and strategies of immunotherapy resistance in colorectal cancer. Front Immunol 13: 1016646. https://doi.org/10.3389/fimmu.2022.1016646 ![]() |
[85] |
Lenz HJ, Van Cutsem E, Luisa Limon M, et al. (2022) First-line nivolumab plus low-dose ipilimumab for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: The phase II CheckMate 142 study. J Clin Oncol 40: 161-170. https://doi.org/10.1200/JCO.21.01015 ![]() |
[86] |
André T, Lonardi S, Wong KYM, et al. (2022) Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142. Ann Oncol 33: 1052-1060. https://doi.org/10.1016/j.annonc.2022.06.008 ![]() |
[87] |
Overman MJ, Gelsomino F, Aglietta M, et al. (2024) Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study. J Immunother Cancer 12: e008689. https://doi.org/10.1136/jitc-2023-008689 ![]() |
[88] |
Lentz RW, Friedrich TJ, Blatchford PJ, et al. (2024) A phase II study of potentiation of pembrolizumab with binimetinib and bevacizumab in refractory microsatellite-stable colorectal cancer. Clin Cancer Res 30: 3768-3778. https://doi.org/10.1158/1078-0432.CCR-24-0090 ![]() |
[89] |
Poto R, Troiani T, Criscuolo G, et al. (2022) Holistic approach to immune checkpoint inhibitor-related adverse events. Front Immunol 13: 804597. https://doi.org/10.3389/fimmu.2022.804597 ![]() |
[90] |
Cunningham M, Gupta R, Butler M (2024) Checkpoint inhibitor hepatotoxicity: pathogenesis and management. Hepatology 79: 198-212. https://doi.org/10.1097/HEP.0000000000000045 ![]() |
[91] |
Wang DY, Salem JE, Cohen JV, et al. (2018) Fatal toxic effects associated with immune checkpoint inhibitors: A systematic review and Meta-analysis. JAMA Oncol 4: 1721-1728. https://doi.org/10.1001/jamaoncol.2018.3923 ![]() |
[92] |
Forbes N, Hilsden RJ, Martel M, et al. (2021) Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes: A systematic review. Clin Gastroenterol Hepatol 19: 1344-1354.e8. https://doi.org/10.1016/j.cgh.2020.09.048 ![]() |
[93] |
Siegel R, DeSantis C, Virgo K, et al. (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62: 220-241. https://doi.org/10.3322/caac.21149 ![]() |
1. | Yangyang Shi, Hongyong Zhao, Xuebing Zhang, Dynamics of a multi-strain malaria model with diffusion in a periodic environment, 2022, 16, 1751-3758, 766, 10.1080/17513758.2022.2144648 | |
2. | Jing Wang, Hongyong Zhao, Bifurcation Analysis of Multiscale Malaria Model with Serratia AS1 Bacteria and Saturated Treatment, 2022, 32, 0218-1274, 10.1142/S0218127422501346 | |
3. | Hengki Tasman, Dipo Aldila, Putri A. Dumbela, Meksianis Z. Ndii, Faishal F. Herdicho, Chidozie W. Chukwu, Assessing the Impact of Relapse, Reinfection and Recrudescence on Malaria Eradication Policy: A Bifurcation and Optimal Control Analysis, 2022, 7, 2414-6366, 263, 10.3390/tropicalmed7100263 | |
4. | Bing He, Lizhong Qiang, On the delayed vector-bias malaria model in an almost periodic environment, 2023, 0, 1531-3492, 0, 10.3934/dcdsb.2023010 | |
5. | Pengfei Liu, Yantao Luo, Zhidong Teng, Role of media coverage in a SVEIR-I epidemic model with nonlinear incidence and spatial heterogeneous environment, 2023, 20, 1551-0018, 15641, 10.3934/mbe.2023698 | |
6. | Bing He, Qi-Ru Wang, Threshold dynamics of a vector-bias malaria model with time-varying delays in environments of almost periodicity, 2024, 78, 14681218, 104078, 10.1016/j.nonrwa.2024.104078 | |
7. | Jing Wang, Hongyong Zhao, Hao Wang, The role of natural recovery category in malaria dynamics under saturated treatment, 2024, 88, 0303-6812, 10.1007/s00285-024-02051-6 | |
8. | Jing Wang, Hongyong Zhao, Threshold dynamics and regional optimal control of a malaria model with spatial heterogeneity and ivermectin therapy, 2024, 125, 0307904X, 591, 10.1016/j.apm.2023.09.006 | |
9. | Jinhui Li, Zhidong Teng, Ning Wang, Wei Chen, Analysis of a delayed malaria transmission model including vaccination with waning immunity and reinfection, 2024, 70, 1598-5865, 3917, 10.1007/s12190-024-02124-1 |
Parameter | Definition | Value(range) | References |
Total human population number | 53 | [24] | |
Natural mortality rate of humans | 0.00157 | [20] | |
Constant recovery rate of humans | (0.04256, 0.5168) | [24] | |
Vector-bias parameter | [13] | ||
Transmission probability | (0.01, 0.27) | [50] | |
from infectious mosquitoes to humans | |||
Diffusion rate of humans | 0.1 | [24] | |
Diffusion rate of mosquitoes | 0.0125 | [24] | |
Transmission probability from | (0.072, 0.64) | [50] | |
infectious humans to mosquitoes per bite | |||
Biting rate of mosquitoes | (E.1) | [20] | |
Death rate of mosquitoes | (E.4) | [20] | |
Maturation delay of | (E.2) | [51] | |
mosquitoes in the aquatic stage | |||
EIP of mosquitoes | (E.3) | [24] | |
Recruitment rate of mosquitoes | (E.5) | [24] | |
Natural death rate for the aquatic stage | (E.6) | [52] |
Parameter | Definition | Value(range) | References |
Total human population number | 53 | [24] | |
Natural mortality rate of humans | 0.00157 | [20] | |
Constant recovery rate of humans | (0.04256, 0.5168) | [24] | |
Vector-bias parameter | [13] | ||
Transmission probability | (0.01, 0.27) | [50] | |
from infectious mosquitoes to humans | |||
Diffusion rate of humans | 0.1 | [24] | |
Diffusion rate of mosquitoes | 0.0125 | [24] | |
Transmission probability from | (0.072, 0.64) | [50] | |
infectious humans to mosquitoes per bite | |||
Biting rate of mosquitoes | (E.1) | [20] | |
Death rate of mosquitoes | (E.4) | [20] | |
Maturation delay of | (E.2) | [51] | |
mosquitoes in the aquatic stage | |||
EIP of mosquitoes | (E.3) | [24] | |
Recruitment rate of mosquitoes | (E.5) | [24] | |
Natural death rate for the aquatic stage | (E.6) | [52] |